MGIM
BRNS

M&G Investment Management’s Barinthus Biotherapeutics BRNS Stock Holding History

M&G Investment Management’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$20.8M Hold
5,197,349
– – 0.07% 122
2023
Q3 		$15.6M Hold
5,197,349
– – 0.07% 149
2023
Q2 		$10.4M Hold
5,197,349
– – 0.04% 198
2023
Q1 		$10.4M Hold
5,197,349
– – 0.05% 180
2022
Q4 		$10.4M Hold
5,197,349
– – 0.05% 175
2022
Q3 		$15.6M Buy
5,197,349
+4,108,752
+377% +$17.4M 0.09% 140
2022
Q2 		$4.35M Hold
1,088,597
– – 0.03% 256
2022
Q1 		$5.44M Hold
1,088,597
– – 0.01% 247
2021
Q4 		$12M Hold
1,088,597
– – 0.03% 186
2021
Q3 		$17.4M Hold
1,088,597
– – 0.04% 216
2021
Q2 		$18.5M Buy
+1,088,597
New +$16.1M 0.05% 200

Other funds holding BRNS

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
JHU
Johns Hopkins University Baltimore, Maryland $1.5B AUM 13.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IIM
Ipswich Investment Management Beverly, Massachusetts $474M AUM 35.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

M&G Investment Management's BRNS Position: Q4 2023 in Review

M&G Investment Management held its Barinthus Biotherapeutics (BRNS) position steady in Q4 2023 at 5,197,349 shares worth $20.8M. The position accounts for 0.07% of the portfolio, ranked #122.

M&G Investment Management first reported a position in BRNS in Q2 2021 and has held it in 11 quarters since. 15 funds tracked by Wall St. Rank hold BRNS as of Q4 2023.

  • M&G Investment Management held 5,197,349 shares of Barinthus Biotherapeutics worth $20.8M as of Q4 2023.
  • M&G Investment Management left its Barinthus Biotherapeutics share count unchanged in Q4 2023.
  • Barinthus Biotherapeutics made up 0.07% of M&G Investment Management's portfolio in Q4 2023, its #122 holding.
  • M&G Investment Management first reported a position in Barinthus Biotherapeutics in Q2 2021 and has held it in 11 quarters since.
  • 15 funds tracked by Wall St. Rank held Barinthus Biotherapeutics as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.